In hepatocellular carcinoma cell lines PTK787 treatment reduced expression of migration-related proteins Rac1 and Rho and significantly inhibited cell migration at higher concentrations than studied herein (>20 μM). The gene discussed is RAC1; the disease is hepatocellular carcinoma.